Back to top
more

Zoetis (ZTS)

(Real Time Quote from BATS)

$173.07 USD

173.07
1,412,360

+2.70 (1.59%)

Updated Nov 7, 2024 12:23 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (81 out of 251)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Why Zoetis (ZTS) is Poised to Beat Earnings Estimates Again

by Zacks Equity Research

Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

JAZZ vs. ZTS: Which Stock Is the Better Value Option?

by Zacks Equity Research

JAZZ vs. ZTS: Which Stock Is the Better Value Option?

Sheraz Mian headshot

Top Stock Reports for Anheuser-Busch, Gilead & Canadian National

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Anheuser-Busch InBev (BUD), Gilead Sciences (GILD) and Canadian National Railway (CNI).

JAZZ vs. ZTS: Which Stock Is the Better Value Option?

by Zacks Equity Research

JAZZ vs. ZTS: Which Stock Is the Better Value Option?

Why Is Zoetis (ZTS) Down 2.5% Since Last Earnings Report?

by Zacks Equity Research

Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The Zacks Analyst Blog Highlights: Intel, Coca-Cola, Starbucks, Caterpillar and Zoetis

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Intel, Coca-Cola, Starbucks, Caterpillar and Zoetis

Sheraz Mian headshot

Top Analyst Reports for Intel, Coca-Cola & Starbucks

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Intel (INTC), Coca-Cola (KO) and Starbucks (SBUX).

JAZZ vs. ZTS: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

JAZZ vs. ZTS: Which Stock Is the Better Value Option?

Sheraz Mian headshot

Top Stock Reports for Tesla, Disney & PepsiCo

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Tesla (TSLA), The Walt Disney Company (DIS) and PepsiCo (PEP).

Zoetis' (ZTS) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Zoetis (ZTS) beats both earnings and sales estimates in the second quarter of 2020.

Zoetis (ZTS) Q2 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Zoetis (ZTS) delivered earnings and revenue surprises of 34.85% and 13.88%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Zoetis (ZTS) to Report Q2 Earnings: What's in the Cards?

by Zacks Equity Research

Zoetis (ZTS) will provide financial updates when it reports second-quarter 2020 results.

Zoetis (ZTS) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

Zoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Coronavirus Woes Impact Gilead's (GILD) Q2 Earnings?

by Zacks Equity Research

Investors will focus on the HIV franchise's performance and the uptake of Yescarta along with updates on experimental coronavirus treatment, when Gilead (GILD) reports second-quarter 2020 results.

Will Zoetis (ZTS) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zoetis (ZTS) Hits 52-Week High, Can the Run Continue?

by Zacks Equity Research

Zoetis (ZTS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zoetis (ZTS) Up 13.1% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

PCRX vs. ZTS: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

PCRX vs. ZTS: Which Stock Is the Better Value Option?

Sheraz Mian headshot

Top Research Reports for Amgen, BHP, Altria & Others

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Amgen (AMGN), BHP Group (BHP) and Altria Group (MO).

Zoetis' (ZTS) Q1 Earnings Beat Estimates, Revenues In Line

by Zacks Equity Research

Zoetis (ZTS) beats on earnings in the first quarter of 2020 while sales meet estimates. Domestic revenues bumped up owing to growth in new parasiticide products and a robust dermatology portfolio.

Zoetis (ZTS) Q1 Earnings and Revenues Top Estimates

by Zacks Equity Research

Zoetis (ZTS) delivered earnings and revenue surprises of 7.95% and 1.00%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Kinjel Shah headshot

Drug/Biotech Stock Q1 Earnings Due on May 6: ZTS, ALXN & More

by Kinjel Shah

Let us take a look at five drug/biotech companies due to release their first-quarter financial results on May 6.

Zoetis (ZTS) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research

Zoetis (ZTS) will provide pipeline updates along with financial numbers for the first quarter in its impending earnings release.

Zoetis (ZTS) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

Zoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Can Zoetis (ZTS) Keep the Earnings Surprise Streak Alive?

by Zacks Equity Research

Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.